Skip to main content

Quoin Pharmaceuticals Ltd 8-K, filed Nov 4, 2026

Quoin Pharmaceuticals Ltd. (QNRX)

8-K 2026-11-04 For: 2026-11-04
View Original
Added on November 04, 2026

About this 8-K

Quoin Pharmaceuticals Ltd filed this 8-K on November 4, 2026.

Quoin Pharmaceuticals Ltd. entered a sales agreement with Leerink Partners LLC on November 4, 2026, enabling at-the-market sales of ADSs, each representing 35 ordinary shares, with a 3.0% commission on gross proceeds. AI summary

Items reported

  • Item 1.01: Entered into a material agreement
  • Item 9.01: Financial statements and exhibits